Joseph Arena was elected to the Board of Directors of Theratechnologies in 2021. He brings extensive experience in the pharmaceutical industry having held several strategic roles including head of regulatory affairs across lines of business’ with Merck and Co. Inc. and Pfizer Inc., respectively.
Mr. Arena retired from Pfizer Inc. in 2021 after serving three years as Vice President, Oncology Products, Global Regulatory Affairs and previously three years as Vice President, Cardiovascular and Metabolic Products.
Prior to joining Pfizer Inc., Mr. Arena spent 27 years at Merck and Co. Inc. where he held increasingly senior roles including Vice President, Therapeutic Area Lead Oncology, Immunology and in vitro Diagnostics.
Mr. Arena received his B.S. in Pharmacy from St. John’s University in Queens, New York. After four years in community and hospital settings, he attended the University of Medicine and Dentistry of New Jersey and received a Ph.D. in Pharmacology, followed by a post-doctoral fellowship in the Physiology Department at the University of Rochester in New York.